Dudediligence.

Nephros, Inc

NEPHNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.5MSep ’24$3.9MDec ’24$4.9MMar ’25$4.4MJun ’25$4.8MSep ’25$4.7MDec ’25$5.2MMar ’26$6.0MJun ’26
Net income, by quarter
$183,000Sep ’24$349,000Dec ’24$558,000Mar ’25$237,000Jun ’25$337,000Sep ’25$62,000Dec ’25$140,000Mar ’26$1.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$10.2M$10.0M$14.2M$14.2M$18.8M
Gross profit$5.6M$4.7M$8.4M$8.7M$11.6M
Operating income−$3.3M−$4.3M−$1.6M$6,000$1.1M
Net income−$3.9M−$7.1M−$1.6M$74,000$1.2M
Operating cash flow−$1.4M−$3.2M$827,000−$492,000$1.6M
Free cash flow−$1.5M−$3.4M$752,000−$547,000none on file
Cash$7.0M$3.6M$4.3M$3.8M$5.4M
Debt$343,000$71,000none on filenone on filenone on file
Shares outstanding10.3M10.3M10.5M10.5M10.6M